Sign in
  1. Home
  2. Companies
  3. China Jo-Jo Drugstores, Inc.
  4. Financial Statements
  5. Income Statement
China Jo-Jo Drugstores, Inc. logo
China Jo-Jo Drugstores, Inc. CJJD

China Jo-Jo Drugstores, Inc. Income Statement 2020-2011 | CJJD

Brief overview of profit and loss at China Jo-Jo Drugstores, Inc.

This overview is based on financial performance over the past five years. Revenue at China Jo-Jo Drugstores, Inc. moved from $76.9 million in 2015 to $117 million in 2020. Overall revenue changed by +52.6%, equal to an annualized rate of about 8.8%. Revenue advanced gradually over the five-year period.

Gross profit changed from 12.4 million dollars to 25.5 million dollars (+105.2%). At the margin level, the figure shifted from 16.2% to 21.8%. Improving gross profitability strengthens the quality of revenue growth.

Over the period, EBITDA shifted from $3.5 million to −$4.9 million, a change of −241.6%. Operating performance weakened relative to revenue. EBITDA margin moved from 4.5% to −4.2%. The margin contraction indicates weaker operating efficiency.

The final result was 857 thousand dollars initially and −5.8 million dollars in the final year. Profit turned into a loss, the most concerning signal in the results.

The five-year change in capitalization reached +31%: from $56.8 million to $74.5 million. Investors assigned a higher value to the business over time.

Summary assessment

The indicators point to a weaker financial profile. The positive side is supported by a larger revenue base and improving gross profitability. The most visible risks are pressure on operating profitability, a narrow EBITDA buffer and a weaker final result. Investors should continue to monitor margins, costs, and earnings quality.

Annual Income Statement China Jo-Jo Drugstores, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 74.5 M 38.2 M 35.1 M 36.3 M 26.7 M 56.8 M 28.3 T 8.96 M 14.4 M 35.9 M

Shares

 32.8 M 28.9 M 25.2 M 20.4 M 16.1 M 15 M 13.9 T 13.6 M 13.6 M 13.3 M

Net Income

 -5.81 M -926 K -17.1 M -5.64 M 447 K 857 K -25.4 M -14.3 M 8.1 M 8.4 M

Revenue

 117 M 108 M 96.1 M 81.5 M 89.1 M 76.9 M 66.2 M 89.5 M 94.4 M 70 M

EBITDA

 -4.92 M 800 K -16.6 M -4.78 M 1.43 M 3.47 M -21.8 M -11.3 M 12.8 M 12.4 M

Operating Expenses

 31.9 M 26 M 36.6 M 20.6 M 17.5 M 10.7 M 25 M 27.2 M 17.1 M 9.56 M

General and Administrative Expenses

 8.11 M 1.72 M 17.8 M 7.68 M 5.18 M 313 K 11.3 M 15 M 8.58 M 4.72 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company China Jo-Jo Drugstores, Inc. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Pharmaceutical retailers industry

Issuer Price % 24h Market Cap Country
BOQI International Medical BOQI International Medical
BIMI
 		- 6.33 % $ 5.86 M chinaChina
Аптеки 36.6 Аптеки 36.6
APTK
 		- - - russiaRussia
Trxade Group Trxade Group
MEDS
 		- 4.55 % $ 5.8 M usaUSA
111 111
YI
 		$ 3.56 -9.87 % $ 620 M chinaChina
Rite Aid Corporation Rite Aid Corporation
RAD
 		- - $ 35.5 M usaUSA
Walgreens Boots Alliance Walgreens Boots Alliance
WBA
 		- - $ 10.3 B usaUSA
PetMed Express PetMed Express
PETS
 		$ 1.98 -1.49 % $ 41.4 M usaUSA
LifeMD LifeMD
LFMD
 		$ 3.64 -5.21 % $ 164 M usaUSA
Greenlane Holdings Greenlane Holdings
GNLN
 		$ 1.68 -6.14 % $ 12.6 M usaUSA